Systematic Alpha Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$335M Buy
+279,303
New +$285M 9% 2
2026
Q1
Sell
-279,303
Closed -$300M 236
2025
Q4
$300M Hold
279,303
9.36% 2
2025
Q3
$213M Hold
279,303
7.01% 2
2025
Q2
$218M Hold
279,303
7.73% 2
2025
Q1
$231M Hold
279,303
8.81% 2
2024
Q4
$216M Hold
279,303
7.94% 2
2024
Q3
$247M Hold
279,303
9.04% 2
2024
Q2
$253M Hold
279,303
9.64% 2
2024
Q1
$217M Hold
279,303
8.71% 2
2023
Q4
$163M Hold
279,303
7.3% 2
2023
Q3
$150M Hold
279,303
7.47% 2
2023
Q2
$131M Hold
279,303
6.35% 2
2023
Q1
$95.9M Hold
279,303
5.04% 3
2022
Q4
$102M Hold
279,303
5.18% 4
2022
Q3
$90.3M Hold
279,303
5.45% 3
2022
Q2
$90.6M Hold
279,303
5.13% 3
2022
Q1
$80M Hold
279,303
3.9% 4
2021
Q4
$77.1M Hold
279,303
3.58% 5
2021
Q3
$71.2M Hold
279,303
3.12% 6
2021
Q2
$75.3M Buy
279,303
+42,703
+18% +$8.58M 3.42% 5
2021
Q1
$44.2M Buy
236,600
+40,500
+21% +$7.92M 2.84% 6
2020
Q4
$33.1M Buy
+196,100
New +$29.3M 3.61% 4

Other funds holding LLY

Systematic Alpha Investments's LLY Position: Q2 2026 in Review

Systematic Alpha Investments opened a new position in Eli Lilly (LLY) in Q2 2026: 279,303 shares worth $335M. The stake represents 9% of the portfolio and ranks #2 among its holdings. This is a return to the name: Systematic Alpha Investments previously reported a position in LLY as recently as Q4 2025.

Systematic Alpha Investments first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Systematic Alpha Investments held 279,303 shares of Eli Lilly worth $335M as of Q2 2026.
  • Eli Lilly was a new Systematic Alpha Investments position in Q2 2026.
  • Eli Lilly made up 9% of Systematic Alpha Investments's portfolio in Q2 2026, its #2 holding.
  • Systematic Alpha Investments first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Systematic Alpha Investments's 13F filing for Q2 2026, filed 13 Aug 2026.